Hologic, Inc (HOLX) last year’s performance of -12.93% is a clear signal for an entertaining trading season.

On Friday, Hologic, Inc (NASDAQ: HOLX) opened lower -1.33% from the last session, before settling in for the closing price of $65.45. Price fluctuations for HOLX have ranged from $64.87 to $84.67 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 6.10% over the last five years. Company’s average yearly earnings per share was noted 4.66% at the time writing. With a float of $220.79 million, this company’s outstanding shares have now reached $225.56 million.

The firm has a total of 7063 workers. Let’s measure their productivity. In terms of profitability, gross margin is 56.18%, operating margin of 23.94%, and the pretax margin is 22.81%.

Hologic, Inc (HOLX) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Hologic, Inc is 1.44%, while institutional ownership is 105.02%. The most recent insider transaction that took place on Dec 04 ’24, was worth 1,897,482. In this transaction Chief Operating Officer of this company sold 24,856 shares at a rate of $76.34, taking the stock ownership to the 27,957 shares. Before that another transaction happened on Dec 04 ’24, when Company’s Officer proposed sale 24,856 for $76.34, making the entire transaction worth $1,897,484.

Hologic, Inc (HOLX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.1 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 4.66% per share during the next fiscal year.

Hologic, Inc (NASDAQ: HOLX) Trading Performance Indicators

Check out the current performance indicators for Hologic, Inc (HOLX). In the past quarter, the stock posted a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.59. Likewise, its price to free cash flow for the trailing twelve months is 12.82.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.16, a number that is poised to hit 1.02 in the next quarter and is forecasted to reach 4.65 in one year’s time.

Technical Analysis of Hologic, Inc (HOLX)

Analysing the last 5-days average volume posted by the [Hologic, Inc, HOLX], we can find that recorded value of 3.57 million was better than the volume posted last year of 2.59 million. As of the previous 9 days, the stock’s Stochastic %D was 35.28%. Additionally, its Average True Range was 1.96.

During the past 100 days, Hologic, Inc’s (HOLX) raw stochastic average was set at 3.44%, which indicates a significant decrease from 7.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.49% in the past 14 days, which was higher than the 25.54% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $72.94, while its 200-day Moving Average is $76.94. Now, the first resistance to watch is $65.81. This is followed by the second major resistance level at $67.04. The third major resistance level sits at $68.00. If the price goes on to break the first support level at $63.61, it is likely to go to the next support level at $62.65. Now, if the price goes above the second support level, the third support stands at $61.42.

Hologic, Inc (NASDAQ: HOLX) Key Stats

There are currently 225,723K shares outstanding in the company with a market cap of 14.49 billion. Presently, the company’s annual sales total 4,030 M according to its annual income of 789,500 K. Last quarter, the company’s sales amounted to 987,900 K and its income totaled 178,600 K.